Team:Washington/Gram Positive

From 2010.igem.org

(Difference between revisions)
(Capsule Depolymerase (CapD):)
(Capsule Creator and Destroyer)
Line 39: Line 39:
==Capsule Creator and Destroyer==
==Capsule Creator and Destroyer==
-
 
-
Anthrax creates a poly-γ-D-glutamate (PDGA) capsule which prevents the immune system from recognizing it as a pathogen and performing phagocytosis to eliminate the threat. Naturally, anthrax excretes a long strand of PDGA and uses its CapD to cleave and anchor the PDGA to its peptidoglycan, the outer coat of the cell membrane, as a protective capsule. CapD can also cut and release its capsule into small pieces that can interfere with the immune responses.
 
[[Image:WashingtonCapDExplanationAfterSpecificitySwitch.png|700px]]
[[Image:WashingtonCapDExplanationAfterSpecificitySwitch.png|700px]]
 +
==Potential Weapon against Anthrax==
==Potential Weapon against Anthrax==
Research based on a guinea pig model (Scorpio et al, 2010) shows overexpression of CapD will destroy the capsule, removing anthrax's immunity to phagocytosis.
Research based on a guinea pig model (Scorpio et al, 2010) shows overexpression of CapD will destroy the capsule, removing anthrax's immunity to phagocytosis.

Revision as of 23:53, 8 October 2010

Contents

Why Anthrax?

Bacillus anthracis

Anthrax is a lethal disease caused by the bacterium Bacillus anthracis, which can spread by ingestion, inhalation, or cutaneous lesion contact of spores. This disease is not contagious, cannot be transferred from an infected organism, though bacterial spores can be transported in a multitude of ways and will infect potential victims.

Bacillus anthracis is found in two forms: spore and vegetative. Spores of Bacillus anthracis are extremely resilient, remaining potent even after enduring the harshest climates for centuries. After spores successfully infect an organism, Bacillus anthracis changes to its vegetative state and begins growth and reproduction. The vegetative state is the source of the anthrax disease. If the vegetative state is exposed to oxygen, it immediately changes to the spore form, becoming infectious once again.

Capsule Depolymerase (CapD):

Anthrax creates a poly-γ-D-glutamate (PDGA) capsule which prevents the immune system from recognizing it as a pathogen and performing phagocytosis to eliminate the threat. Naturally, anthrax excretes a long strand of PDGA and uses its CapD to cleave and anchor the PDGA to its peptidoglycan, the outer coat of the cell membrane, as a protective capsule. CapD can also cut and release its capsule into small pieces that can interfere with the immune responses.

WashingtonCapDExplanation.png

Capsule Creator and Destroyer

WashingtonCapDExplanationAfterSpecificitySwitch.png

Potential Weapon against Anthrax

Research based on a guinea pig model (Scorpio et al, 2010) shows overexpression of CapD will destroy the capsule, removing anthrax's immunity to phagocytosis. CapD is naturally a transpeptidase, favoring reactions with amino acids to cleave PDGA. However, CapD would be invaluable as a hydrolase, reacting efficiently with water, because of high water content in the human bloodstream. If a mutant CapD could be engineered as an extremely efficient hydrolase, it is theorized that a single dose of concentrated CapD into the blood stream would easily decimate anthrax populations, nullifying its lethal properties.




Overview       Designing the Gram(+) Therapeutic